e-learning
resources
Munich 2014
Monday, 08.09.2014
Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation
Y. Batyrshina, T. Petrenko (Novosibirsk, Russian Federation)
Source:
International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Session:
Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Session type:
Thematic Poster Session
Number:
2615
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Batyrshina, T. Petrenko (Novosibirsk, Russian Federation). Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation. Eur Respir J 2014; 44: Suppl. 58, 2615
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The risk of default in TB patients in the Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Risk factors associated with fluoroquinolones-resistance of M.tuberculosis in Novosibirsk Oblast, Russian Federation: Results of retrospective cohort study
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast of the Russian Federation
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008
Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
MDR TB treatment results of GFATM program implementation in Tomsk, Russia
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Improvement of TB epidemiological situation in Tomsk Oblast within the MDR-TB treatment program
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008
Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Trend in TB control in Republic of Moldova: High MDRTB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Risk factors for anti-TB drug resistance in Poland
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Treatment outcomes of new TB cases among children in Russia
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Out-patient MDR-TB care in Moldova
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept